Diabetes, Lipids and Vascular Risk: A
Physiologic Approach
Mehmood Kahn, MD, FACE,
Senior Vice President, Medical and Scientific Affairs,
Takeda Pharmaceuticals, North America.
May 02, 2006
12:00-1:00 P.M.
Levin Hall 5th Floor
Watch
archived presentation
(requires Windows Media Player
and Internet Explorer)
Objectives:
- Review physiology of lipid
metabolism in normal humans
- Discuss reverse cholesterol
transport and triglyceride transport
- Identify potential targets
for future atherosclerosis management
Accreditation Statement:
The University of Texas Medical Branch at Galveston is
accredited by the Accreditation Council for Continuing Medical
Education to provide continuing medical education for
physicians. Designation Statement: The University of Texas
Medical Branch at Galveston designates this educational activity
for a maximum of 1 AMA PRA category 1 creditTM. Physicians
should claim only credit commensurate with the extent of their
participation in the activity.
This program (#2005-676) has also been approved by the American
Association of Critical-Care Nurses (AACN) – approved provider
(#00012890) under established AACN guidelines for 1.0 contact
hours, CERP Category A.
Methodology:
Lecture followed by question and answer session.
Disclosure Statement:
Dr. Khan is an employee of Takeda Pharmaceuticals.
Frequent thirst
Archived Teleconference: